Urine can remain the standard specimen for a DOT drug testing program. I generally recommend it as a starting choice for pre-employment and routine random testing. Oral fluid may be useful for other testing situations once it is available, but the decision depends on what you need the test to detect and how the collection will work.
As of October 13, 2026, DOT’s laboratory and device list still shows no HHS-certified oral fluid laboratories. At least two are required before DOT use can begin. Employers can compare their options now while continuing urine testing.
The comparison below covers detection, observation, collection readiness and cost. Neither specimen establishes current impairment, and neither guarantees a faster or less expensive collection.
| Consideration | Oral fluid | Urine |
|---|---|---|
| Detection | May provide a better indication of recent use. Detection varies with the drug, dose, route and pattern of use. No universal detection window applies. | May detect use over a longer period. Detection also varies with the drug, dose, route and pattern of use. |
| Observation | The collector watches the employee position the device and provide the specimen during every collection. | Direct observation is required in specific circumstances. A same-sex observer must be in the bathroom with the employee and watch urine leave the employee’s body and enter the collection container. This includes return-to-duty and follow-up testing. |
| Collection readiness | Requires a qualified oral-fluid collector and a compatible, unexpired device approved for the laboratory. The employer or clinic may supply it. | Uses the urine collection arrangements in your existing program. Confirm that the site can meet the requirements for the test ordered. |
| DOT availability | DOT’s page still listed no certified oral-fluid labs when checked October 13, 2026. At least two are required before use can begin. | Remains available for DOT drug testing. |
| Insufficient specimen | If the collection continues with oral fluid, the dry-mouth procedure allows up to one hour to provide a sufficient specimen. | If the collection continues with urine, the shy-bladder procedure allows up to three hours to provide a sufficient specimen. |
| Operating cost | Compare collection charges separately from lab charges. Clarify device costs and who supplies them. Include employee time away from work; oral fluid does not guarantee a faster collection. | Compare collection charges separately from lab charges, any direct-observation charges and employee time away from work. |
Detection windows have limits
A detection window is the period during which a test can identify a drug or its metabolites in a specimen. It does not tell you exactly when the employee used the drug or whether the employee is currently impaired. Oral fluid may give a better indication of recent use. Urine may detect use over a longer period. Those differences can help inform the specimen choice, but they do not produce a single reliable number of hours for every drug or every employee.
In its 2023 final rule, DOT removed the proposed detection-window table after comments identified important limitations. Detection depends on factors such as the drug, dose, route of administration and pattern of use. There is no single detection period that applies to every substance or use circumstance.
A positive oral-fluid result does not establish that drug use caused an accident. A negative result does not replace the employer’s assessment of observed behavior or other safety information. Discuss the specific drugs and testing circumstances with your testing administrator and Medical Review Officer rather than choosing a specimen from a general hours chart.
Choosing by testing reason
For pre-employment and routine random testing, the potentially longer detection period and the existing urine collection arrangements are useful considerations. Employers may reach a different decision after reviewing their own program.
For post-accident and reasonable-suspicion testing, oral fluid is a potential option because recent use is relevant to those situations. That recommendation applies once DOT oral-fluid testing is available and the collection can be performed properly. It does not mean an oral-fluid result measures impairment or proves the cause of an accident.
Do not delay a required test while trying to obtain your preferred specimen. Follow the applicable DOT agency’s requirements and use a collection option that is available and authorized. The timing and circumstances that trigger a post-accident test are separate from the specimen choice.
The Part 40 specimen rule allows either urine or oral fluid, but prohibits collecting both simultaneously at the start of the same testing event. A collection problem may justify changing specimen types under the applicable procedures. The employer’s instructions matter; the employee does not choose the specimen at the collection site.
Observed collection and site readiness
Every DOT oral-fluid collection is observed. The collector watches the employee position the device in the mouth and provide the specimen. For a directly observed urine collection, a same-sex observer must be in the bathroom with the employee and watch urine leave the employee’s body and enter the collection container. Direct observation is required for return-to-duty and follow-up urine tests, as well as other specified situations. See 49 CFR 40.73 and 49 CFR 40.67.
Once oral-fluid testing is available, it may simplify the arrangements for an observed collection because the oral-fluid collector can perform the observation. Employers should still confirm the site’s readiness. When a same-sex urine observer cannot be found, Section 40.67 requires oral fluid once it is available, subject to its transition provisions. An 18-month transition begins when HHS gives notice of a second certified oral-fluid laboratory. DOT will announce the start and end dates. During that period, an employer that has decided to use oral fluid and is ready to do so must use it in this situation.
Observation does not make oral-fluid testing tamper-proof. Part 40 includes procedures for suspected tampering.
Comparing the full cost of a test
A higher collection or laboratory charge might be offset by less employee time away from work or different direct-observation arrangements. There is no universal cost answer.
Compare the actual costs for your program:
- Collection charges for each specimen.
- Laboratory charges for each specimen.
- Device charges, including whether the clinic’s collection price includes the device or the employer will supply it.
- Direct-observation fees, where applicable.
- Employee travel and waiting time.
Oral fluid can also present an insufficient-specimen problem. If the collection continues with the original specimen type, 49 CFR 40.193 provides different procedures for shy bladder and dry mouth. The urine procedure allows up to three hours; the oral-fluid procedure allows up to one hour. Neither period is the normal duration of a successful collection. Section 40.193 permits a change to an alternate specimen at the initial insufficient-specimen point, following employer instructions and using a qualified collector. Decide that approach in advance. Do not build a procedure around an arbitrary switch partway through the waiting period.
Making the choice work in your program
Review your testing reasons and identify the preferred specimen for each. Start preparing with the clinics your employees use now. If you plan to collect at your workplace, confirm qualified staff and usable device supplies there too. Confirm collector qualifications and agree who will supply the devices. Employers may provide compatible devices, or clinics may include them in their collection service. Either way, the site needs the device approved for your laboratory, within its expiration date, and an appropriately qualified collector. DOT laboratory and device list, 49 CFR 40.35, 49 CFR 40.72.
Confirm the collection charge, laboratory charge and any device charge before changing the program. Put the specimen choices and permitted alternatives in instructions your collection providers can use. Address insufficient specimens and what should happen when an oral-fluid collection cannot be performed. 49 CFR 40.14 requires employers to provide collection information, including the specimen type. A standing order is one way to communicate those decisions; DOT does not require every employer to use one universal standing-order form.
Employers can retain urine as their standard method while preparing to add oral fluid where it is useful. Any change should fit the written policy and the procedures that apply to the test. Keep DOT and non-DOT testing separate, as required by 49 CFR 40.13.
Employers can contact A WorkSAFE Service for help reviewing specimen choices and collection instructions in their current drug and alcohol policy.
Watch the oral fluid webinar
This September 23, 2026 recording predates the October 6 FDA order. The availability and regulatory updates in this article were checked October 13, 2026.
